News Feed
Events By OncoDaily
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Immune Oncology
Breast Oncology
Gastrointestinal Oncology
Genitourinary Oncology
Lung Oncology
Hematology
Radiotherapy
Cancer Types
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Oncologist Near Me

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
Global Cancer Movement
History
Oncolibrary
OncoThon 2025

OncoDaily Washington DC
OncoDaily India
OncoDaily Brazil
OncoDaily Algeria
OncoDaily Kenya

Yvonne Awards
OncoDaily Party
How I Treat
O Series
Global Oncothon

OncoDaily Medical Journal
OncoDaily Newsletters
OncoDaily Magazine
CancerWorld Magazine
World Health Magazine
BIGR
Hemostasis Today
Fertility News

OncoDaily GI
OncoDaily Breast
OncoDaily IO
OncoDaily Lung
OncoDaily RT
OncoDaily GU
OncoDaily AI
OncoDaily Biotech
Hematology

Services
Partners
Contact us
About OncoDaily
P53 Inc
Privacy Policy
Editorial Policy
Disclaimer
Cookie Policy

Sep / 2026

September 2026
M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

« Aug

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
Events By OncoDaily
OncoGrants
OncoDaily TV
NewsLetter

OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Immuno 2026 Opens with Global Leaders Exploring the Next Decade of Cancer Immunotherapy

Rare Cells, Big Stories: What Circulating Tumor Cells Can Tell Us About Cancer

Global Cancer Leaders Gather in Brussels to Mark 10 Years of World Cancer Research Day

Integrated utDNA and ctDNA Testing in Upper Tract Urothelial Carcinoma

Sjoerd Hubben: A Call to Strengthen Europe’s Pharma Innovation Ecosystem

FDA Approved Lirafugratinib for FGFR2 Fusion or Rearrangement–Positive Cholangiocarcinoma

Mike Bloomberg: Honored to be Reappointed as the WHO Global Ambassador for NCDs and Injuries

Cancer In US Media: 2026

Erika Florendo

Jan 11, 2026 6:00 pm

Voices

Myeloma Paper of the Day, January 11th, Suggested by Robert Orlowski

Jan 10, 2026 4:42 pm

Voices

Yan Leyfman: CARTITUDE-4 Update – Deeper and More Durable Benefit with Cilta-Cel in Lenalidomide-Refractory Multiple Myeloma

$Yan Leyfman: CARTITUDE-4 Update – Deeper and More Durable Benefit with Cilta-Cel in Lenalidomide-Refractory Multiple Myeloma$

Oct 28, 2024 6:36 am

Positive

CARVYKTI® (ciltacabtagene autoleucel) was Awarded the Johnson Medal

Headlines

Can the Microbiome Change How Cancer Responds to Radiation Therapy?

Oct 28, 2024

The State of Oncology in 2026 With ZS: A Look at the Forces Reshaping Cancer Care

Oct 28, 2024

UK Approves Lurbinectedin Plus Atezolizumab as First-Line Maintenance Therapy for Small Cell Lung Cancer

Oct 28, 2024

Bishal Gyawali: Why Access to Clinical Trials Is an Important Equity Metric

Oct 28, 2024

Meet-URO 33 Study: Bone Metastases, SREs and Bone-Targeted Agents in mRCC

Oct 28, 2024

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer Breast Cancer cancer care ASCO Lung cancer Cancer research fight against cancer Global fight against cancer Headlines immunotherapy ESMO NSCLC cancer treatment clinical trials MD Anderson Cancer Center colorectal cancer cancer awareness prostate cancer FDA Childhood Cancer Research UICC AACR ASCO24 chemotherapy Pancreatic Cancer radiation oncology Dana-Farber Cancer Institute Precision Oncology AI SIOP American Cancer Society Robert Orlowski American Society of Clinical Oncology NCI European Cancer Organisation National Cancer Institute radiotherapy WHO Myeloma Paper of the Day cervical cancer IASLC Paolo Tarantino Myeloma Vivek Subbiah bladder cancer multiple myeloma Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}